Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D(3) as host directed therapy

BACKGROUND: We have previously shown that 8 weeks’ treatment with phenylbutyrate (PBA) (500mgx2/day) with or without vitamin D(3) (vitD(3)) (5000 IU/day) as host-directed therapy (HDT) accelerated clinical recovery, sputum culture conversion and increased expression of cathelicidin LL-37 by immune c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Rekha, Rokeya Sultana, Mily, Akhirunnesa, Sultana, Tajnin, Haq, Ahsanul, Ahmed, Sultan, Mostafa Kamal, S. M., van Schadewijk, Annemarie, Hiemstra, Pieter S., Gudmundsson, Gudmundur H., Agerberth, Birgitta, Raqib, Rubhana
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033279/
https://ncbi.nlm.nih.gov/pubmed/29973153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-3203-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados